skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 41 - 60 of 151,194  for All Library Resources

previous page 1 2 Results 3 4 5 next page
Refined by: subject: Cancer remove
Result Number Material Type Add to My Shelf Action Record Details and Options
41
Biden's science adviser resigns over bullying
Material Type:
Article
Add to My Research

Biden's science adviser resigns over bullying

The Lancet (British edition), 2022-02, Vol.399 (10326), p.705-705 [Peer Reviewed Journal]

2022 Elsevier Ltd ;2022. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(22)00308-7 ;PMID: 35183287

Full text available

42
African scientists call for research equity as a cancer crisis looms
Material Type:
Article
Add to My Research

African scientists call for research equity as a cancer crisis looms

Nature (London), 2023-09, Vol.621 (7977), p.S16-S17 [Peer Reviewed Journal]

ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/d41586-023-02610-9 ;PMID: 37674000

Digital Resources/Online E-Resources

43
Neoantigen identification strategies enable personalized immunotherapy in refractory solid tumors
Material Type:
Article
Add to My Research

Neoantigen identification strategies enable personalized immunotherapy in refractory solid tumors

The Journal of clinical investigation, 2019-05, Vol.129 (5), p.2056-2070 [Peer Reviewed Journal]

COPYRIGHT 2019 American Society for Clinical Investigation ;COPYRIGHT 2019 American Society for Clinical Investigation ;Copyright American Society for Clinical Investigation May 2019 ;2019 American Society for Clinical Investigation 2019 American Society for Clinical Investigation ;ISSN: 0021-9738 ;EISSN: 1558-8238 ;DOI: 10.1172/JCI99538 ;PMID: 30835255

Full text available

44
Addressing disparities in funding for robust cancer research
Material Type:
Article
Add to My Research

Addressing disparities in funding for robust cancer research

Therapeutic advances in vaccines and immunotherapy, 2023-01, Vol.11 [Peer Reviewed Journal]

The Author(s), 2023 ;The Author(s), 2023. This work is licensed under the Creative Commons Attribution – Non-Commercial License https://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2515-1355 ;EISSN: 2515-1363 ;DOI: 10.1177/25151355231219083

Full text available

45
Neutrophil extracellular traps in immunity and disease
Material Type:
Article
Add to My Research

Neutrophil extracellular traps in immunity and disease

Nature reviews. Immunology, 2018-02, Vol.18 (2), p.134-147 [Peer Reviewed Journal]

COPYRIGHT 2018 Nature Publishing Group ;COPYRIGHT 2018 Nature Publishing Group ;Copyright Nature Publishing Group Feb 2018 ;ISSN: 1474-1733 ;EISSN: 1474-1741 ;DOI: 10.1038/nri.2017.105 ;PMID: 28990587

Full text available

46
A cancer's ties to its neighbours
Material Type:
Article
Add to My Research

A cancer's ties to its neighbours

Nature (London), 2018-12, Vol.564 (7736), p.304 [Peer Reviewed Journal]

Copyright Nature Publishing Group Dec 20-Dec 27, 2018 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/d41586-018-07752-9

Full text available

47
Of scientists and tweets
Material Type:
Article
Add to My Research

Of scientists and tweets

Nature reviews. Cancer, 2019-09, Vol.19 (9), p.479-480 [Peer Reviewed Journal]

COPYRIGHT 2019 Nature Publishing Group ;COPYRIGHT 2019 Nature Publishing Group ;Copyright Nature Publishing Group Sep 2019 ;ISSN: 1474-175X ;EISSN: 1474-1768 ;DOI: 10.1038/s41568-019-0170-4 ;PMID: 31253855

Full text available

48
HOW SCIENTIFIC JOURNALS ARE FIGHTING BACK AGAINST A TORRENT OF QUESTIONABLE IMAGES
Material Type:
Article
Add to My Research

HOW SCIENTIFIC JOURNALS ARE FIGHTING BACK AGAINST A TORRENT OF QUESTIONABLE IMAGES

Nature (London), 2024-02, Vol.626 (8000), p.697-698 [Peer Reviewed Journal]

Copyright Nature Publishing Group Feb 22, 2024 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/d41586-024-00372-6

Digital Resources/Online E-Resources

49
Pancreatic duct ligation reduces premalignant pancreatic lesions in a Kras model of pancreatic adenocarcinoma in mice
Material Type:
Article
Add to My Research

Pancreatic duct ligation reduces premalignant pancreatic lesions in a Kras model of pancreatic adenocarcinoma in mice

The Author(s) 2020. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. http://creativecommons.org/licenses/by/4.0/ info:eu-repo/semantics/openAccess ;ISSN: 2045-2322 ;EISSN: 2045-2322 ;DOI: 10.1038/s41598-020-74947-4

Full text available

50
Reporting of prognostic clinical prediction models based on machine learning methods in oncology needs to be improved
Material Type:
Article
Add to My Research

Reporting of prognostic clinical prediction models based on machine learning methods in oncology needs to be improved

Journal of clinical epidemiology, 2021-10, Vol.138, p.60-72 [Peer Reviewed Journal]

2021 The Authors ;Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved. ;2021. The Authors ;2021 The Authors 2021 ;ISSN: 0895-4356 ;EISSN: 1878-5921 ;DOI: 10.1016/j.jclinepi.2021.06.024 ;PMID: 34214626

Full text available

51
Reengineering the clinical research enterprise to involve more community clinicians
Material Type:
Article
Add to My Research

Reengineering the clinical research enterprise to involve more community clinicians

Implementation science : IS, 2011-04, Vol.6 (1), p.36-36, Article 36 [Peer Reviewed Journal]

COPYRIGHT 2011 BioMed Central Ltd. ;Copyright BioMed Central 2011 ;Copyright ©2011 Ryan et al; licensee BioMed Central Ltd. 2011 Ryan et al; licensee BioMed Central Ltd. ;ISSN: 1748-5908 ;EISSN: 1748-5908 ;DOI: 10.1186/1748-5908-6-36 ;PMID: 21463518

Full text available

52
388 Efficacy of individualised starting dose (ISD) and fixed starting dose (FSD) of niraparib per investigator assessment (IA) in newly diagnosed advanced ovarian cancer (OC) patients
Material Type:
Article
Add to My Research

388 Efficacy of individualised starting dose (ISD) and fixed starting dose (FSD) of niraparib per investigator assessment (IA) in newly diagnosed advanced ovarian cancer (OC) patients

International journal of gynecological cancer, 2020-12, Vol.30 (Suppl 4), p.A90-A91 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. ;2020 Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1048-891X ;EISSN: 1525-1438 ;DOI: 10.1136/ijgc-2020-ESGO.154

Full text available

53
Use of online dietary recalls to assess adherence to dietary guidelines in people living with and beyond cancer: feasibility and process requirements for ASCOT
Material Type:
Article
Add to My Research

Use of online dietary recalls to assess adherence to dietary guidelines in people living with and beyond cancer: feasibility and process requirements for ASCOT

Proceedings of the Nutrition Society, 2020, Vol.79 (OCE1), Article E26 [Peer Reviewed Journal]

Copyright Cambridge University Press 2020 ;ISSN: 0029-6651 ;EISSN: 1475-2719 ;DOI: 10.1017/S0029665119001472

Full text available

54
Panel Addresses How Payers, Providers Can Optimally Use Real-World Evidence to Advance Cancer Care
Material Type:
Article
Add to My Research

Panel Addresses How Payers, Providers Can Optimally Use Real-World Evidence to Advance Cancer Care

The American journal of managed care, 2023-02 [Peer Reviewed Journal]

COPYRIGHT 2023 Intellisphere, LLC ;ISSN: 1088-0224 ;EISSN: 1936-2692

Full text available

55
Women in contemporary cancer research
Material Type:
Article
Add to My Research

Women in contemporary cancer research

International journal of cancer, 2020-09, Vol.147 (6), p.1571 [Peer Reviewed Journal]

2020 UICC. ;EISSN: 1097-0215 ;DOI: 10.1002/ijc.32938 ;PMID: 32086947

Digital Resources/Online E-Resources

56
The importance of patient-reported outcomes in clinical trials and strategies for future optimization
Material Type:
Article
Add to My Research

The importance of patient-reported outcomes in clinical trials and strategies for future optimization

Patient related outcome measures, 2018-01, Vol.9, p.353-367 [Peer Reviewed Journal]

COPYRIGHT 2018 Dove Medical Press Limited ;COPYRIGHT 2018 Dove Medical Press Limited ;2018. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2018 Mercieca-Bebber et al. This work is published and licensed by Dove Medical Press Limited 2018 ;ISSN: 1179-271X ;EISSN: 1179-271X ;DOI: 10.2147/prom.s156279 ;PMID: 30464666

Full text available

57
The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis
Material Type:
Article
Add to My Research

The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis

The Lancet (British edition), 2012-03, Vol.379 (9822), p.1214-1224 [Peer Reviewed Journal]

Elsevier Ltd ;2012 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2012 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Mar 31-Apr 6, 2012 ;2012 Elsevier Ltd. All rights reserved. 2012 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(12)60110-X ;PMID: 22421340 ;CODEN: LANCAO

Full text available

58
Cuts in cancer research funding due to COVID-19
Material Type:
Article
Add to My Research

Cuts in cancer research funding due to COVID-19

The lancet oncology, 2021-01, Vol.22 (1), p.e6-e6 [Peer Reviewed Journal]

2021 Elsevier Ltd ;2021. Elsevier Ltd ;2020 Elsevier Ltd. All rights reserved. 2021 Elsevier Ltd ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(20)30749-X ;PMID: 33341123

Full text available

59
Realizing the Potential of Cancer Prevention — The Role of Implementation Science
Material Type:
Article
Add to My Research

Realizing the Potential of Cancer Prevention — The Role of Implementation Science

The New England journal of medicine, 2017-03, Vol.376 (10), p.986-990 [Peer Reviewed Journal]

Copyright © 2017 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMsb1609101 ;PMID: 28273020

Full text available

60
Reframing the "Cancer Moonshot"
Material Type:
Article
Add to My Research

Reframing the "Cancer Moonshot"

EMBO reports, 2016-12, Vol.17 (12), p.1685-1687 [Peer Reviewed Journal]

2016 The Author ;ISSN: 1469-221X ;EISSN: 1469-3178 ;DOI: 10.15252/embr.201643467 ;CODEN: ERMEAX

Full text available

Results 41 - 60 of 151,194  for All Library Resources

previous page 1 2 Results 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
  1. Before 1961  (111)
  2. 1961 To 1976  (178)
  3. 1977 To 1992  (1,796)
  4. 1993 To 2009  (17,304)
  5. After 2009  (132,078)
  6. More options open sub menu

Subject 

  1. Medical Research  (146,289)
  2. Science & Technology  (40,669)
  3. Life Sciences & Biomedicine  (30,400)
  4. Humans  (26,812)
  5. Oncology  (26,453)
  6. Tumors  (24,076)
  7. Patients  (18,103)
  8. Clinical Trials  (16,573)
  9. Medicine, Experimental  (14,388)
  10. Cancer Therapies  (14,106)
  11. Proteins  (13,202)
  12. Biotechnology Industry  (13,134)
  13. Research & Development  (11,849)
  14. R&d  (11,848)
  15. Care And Treatment  (11,472)
  16. Female  (11,451)
  17. Medicine  (11,440)
  18. Chemotherapy  (10,943)
  19. Immunotherapy  (10,779)
  20. More options open sub menu

Language 

  1. English  (150,864)
  2. Japanese  (6,077)
  3. French  (161)
  4. German  (148)
  5. Spanish  (124)
  6. Portuguese  (68)
  7. Norwegian  (51)
  8. Chinese  (37)
  9. Turkish  (31)
  10. Hindi  (21)
  11. Urdu  (6)
  12. Arabic  (6)
  13. Russian  (3)
  14. Dutch  (3)
  15. Hungarian  (2)
  16. Serbian  (2)
  17. Afrikaans  (2)
  18. Latin  (1)
  19. Italian  (1)
  20. Croatian  (1)
  21. More options open sub menu

Searching Remote Databases, Please Wait